Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells 2020; 12(4): 277-287 [PMID: 32399136 DOI: 10.4252/wjsc.v12.i4.277]
Corresponding Author of This Article
Jing-Li Sun, MAMS, Chief Physician, Department of Obstetrics and Gynecology, General Hospital of Northern Theater Command (Heping Campus), No. 5 Guangrong Street, Heping District, Shenyang 110000, Liaoning Province, China. zg3416@sina.com
Research Domain of This Article
Obstetrics & Gynecology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Stem Cells. Apr 26, 2020; 12(4): 277-287 Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.277
Table 1 The number of mice in the normal oestrus cycle at each time point in each group
Groups
1-15 d
16-30 d
31-45 d
46-60 d
Negative control group
20
15
10
5
Model group
0
0
0
0
hUCMSC group
0
7
4
3
Positive control group
0
6
4
4
Table 2 Comparison of ovarian weight in each group at each time point
Items
After transplantation
1 d
15 d
30 d
45 d
60 d
Negative control group
36.67 ± 0.68
36.97 ± 0.32
37.45 ± 0.35
34.86 ± 0.43
38.13 ± 0.35
Model group
23.19 ± 0.98
20.23 ± 0.49
18.30 ± 0.28
18.02 ± 0.41
17.25 ± 0.28
hUCMSC group
21.19 ± 0.65
19.54 ± 0.27
21.77 ± 0.48
23.11 ± 0.38
24.28 ± 0.48
Positive control group
22.50 ± 0.62
19.30 ± 0.37
24.53 ± 0.93
27.64 ± 0.34
28.06 ± 0.93
P value
P < 0.05
Table 3 E2 concentration of each group at each time point
Items
Before transplantation
After transplantation
1 d
15 d
30 d
45 d
60 d
Negative control group
56.94 ± 4.43
51.42 ± 2.35
53.99 ± 2.73
53.43 ± 3.26
52.04 ± 1.65
55.43 ± 1.57
Model group
55.23 ± 4.35 (P = 0.147)
35.41 ± 2.25
28.32 ± 1.51
24.86 ± 0.90
22.16 ± 1.25
18.99 ± 1.40
hUCMSC group
55.83 ± 3.35 (P = 0.325)
37.84 ± 1.69
38.33 ± 1.79
35.04 ± 2.31
35.12 ± 1.47
34.10 ± 1.42
Positive control group
55.03 ± 3.43 (P = 0.357)
37.34 ± 1.86
37.80 ± 1.83
36.86 ± 2.09
36.86 ± 1.11
37.08 ± 1.47
P value
P > 0. 05
Table 4 Follicle-stimulating hormone concentration of each group at each time point
Items
Before transplantation
After transplantation
1 d
15 d
30 d
45 d
60 d
Negative control group
8.61 ± 0.03
9.25 ± 0.35
8.64 ± 0.56
9.27 ± 0.36
8.93 ± 0.26
9.11 ± 0.10
Model group
8.76 ± 0.17 (P = 0.19)
18.33 ± 0.79
20.36 ± 0.74
22.38 ± 1.05
24.26 ± 1.15
25.19 ± 0.96
hUCMSC group
8.70 ± 0.38 (P = 0.93)
19.44 ± 1.23
14.07 ± 0.53
15.52 ± 0.57
18.22 ± 1.14
18.55 ± 0.66
Positive control group
8.66 ± 0.45 (P = 0.10)
18.5 ± 0.31
12.50 ± 0.63
12.39 ± 0.03
13.50 ± 1.04
14.28 ± 0.64
P value
P > 0. 05
Citation: Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells 2020; 12(4): 277-287